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Abstract
The primordium of the limb contains a number of progenitors far superior to those necessary to form the skeletal
components of this appendage. During the course of development, precursors that do not follow the skeletogenic
program are removed by cell senescence and apoptosis. The formation of the digits provides the most representative
example of embryonic remodeling via cell degeneration. In the hand/foot regions of the embryonic vertebrate limb
(autopod), the interdigital tissue and the zones of interphalangeal joint formation undergo massive degeneration that
accounts for jointed and free digit morphology. Developmental senescence and caspase-dependent apoptosis are
considered responsible for these remodeling processes. Our study uncovers a new upstream level of regulation of
remodeling by the epigenetic regulators Uhrf1 and Uhrf2 genes. These genes are spatially and temporally expressed in
the pre-apoptotic regions. UHRF1 and UHRF2 showed a nuclear localization associated with foci of methylated
cytosine. Interestingly, nuclear labeling increased in cells progressing through the stages of degeneration prior to
TUNEL positivity. Functional analysis in cultured limb skeletal progenitors via the overexpression of either UHRF1 or
UHRF2 inhibited chondrogenesis and induced cell senescence and apoptosis accompanied with changes in global
and regional DNA methylation. Uhrfs modulated canonical cell differentiation factors, such as Sox9 and Scleraxis,
promoted apoptosis via up-regulation of Bak1, and induced cell senescence, by arresting progenitors at the S phase
and upregulating the expression of p21. Expression of Uhrf genes in vivo was positively modulated by FGF signaling. In
the micromass culture assay Uhrf1 was down-regulated as the progenitors lost stemness and differentiated into
cartilage. Together, our ﬁndings emphasize the importance of tuning the balance between cell differentiation and cell
stemness as a central step in the initiation of the so-called “embryonic programmed cell death” and suggest that the
structural organization of the chromatin, via epigenetic modiﬁcations, may be a precocious and critical factor in these
regulatory events.
Introduction
The autopod is a paddle shaped structure consisting of a
core of skeletal progenitors covered by the ectoderm.
During the course of development, the progenitors
aggregate to form radial digit condensations separated by
interdigital regions. Cells in the interdigital regions are
initially undifferentiated but soon follow massive degen-
eration that sculpts the digit contours. In chick and mouse
embryos the elimination of the interdigital tissue lasts
more than 30 h. During this period the interdigital cells
retain stemness to respond to differentiation signals to
form ectopic digits1.
The control of interdigit remodeling has been the subject
of intense research. Morphological and molecular analyses
revealed the redundant involvement of several degenerative
pathways including canonical apoptosis, cell death
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associated with lysosomal activation2,3, and cell senescence4.
All these degenerative routes are preceded by intense DNA
damage5, which is suggestive of common upstream reg-
ulation. BMPs have been identiﬁed as active factors
responsible for interdigit regression. However, while the
interdigital application of exogenous BMPs in the
embryonic limb induces cell death and DNA damage, the
same BMPs stimulate cell proliferation and differentiation
in the tip of the ﬁngers, that are also constituted by the
same skeletal progenitors6. This ﬁnding suggests that
complementary signals cooperate with BMPs to trigger the
degenerative events. The hypothesis of the present study is
that the embryonic degenerative processes may share reg-
ulatory factors occurring in tumor tissues. DNA damage,
cell senescence, and apoptosis are associated with epige-
netic and chromatin architecture alterations of cancerous
cells7 that may determine tumorigenesis and sensitivity to
chemotherapy and irradiation8,9.
In this study, we analyzed whether ubiquitin-like con-
taining plant homeodomain and RING ﬁnger domain
(UHRF) epigenetic modulators 1 and 2 participate in the
degenerative processes associated with digit development.
This gene family is functionally associated with DNA
damage and participates in the regulation of proliferation
and cell survival of numerous malignancies10. UHRF
proteins are complex factors containing four functional
domains that modulate transcriptional regulation via
chromatin modiﬁcations. Uhrf genes are upregulated in
many cancer cells and may behave as either oncogenes or
tumor suppressors10. Depletion of UHRF1 increases the
chemosensitivity of cancer cells to hydroxyurea resis-
tance11 and increases their sensitivity to gamma-
irradiation12. UHRF2, in turn, has been characterized as
a component of the ubiquitin proteasome degradation
machinery13 with pro-apoptotic functions in oncogene-
stressed cells14. The signiﬁcance of Uhrf genes in devel-
opmental systems has received less attention. Mice and
zebraﬁsh deﬁcient in UHRF1 die during the course of
development15,16, and embryonic stem cells null for
UHRF1 are hypersensitive to DNA-damaging agents15.
Furthermore, Uhrf1 knockout directed to limb mesoderm
implicates this protein in appendicular development17, as
these mice show shortened long bones and dysregulated
chondrocyte maturation and proliferation via alterations
of the growth plate. Uhrf2 knockout mice are viable and
lack morphological defects18, but there is evidence of its
implication in the pathogenesis of neurodegenerative
diseases19. Here, we show that Uhrf1 and Uhrf2 genes are
expressed in the interdigital mesoderm and inter-
phalangeal joints where undifferentiated cells undergo
senescence and apoptosis. At protein level UHRFs asso-
ciated with zones of DNA methylation. Functional ana-
lysis via the overexpression of either UHRF1 or UHRF2
inhibited chondrogenesis and induced cell senescence and
apoptosis of cultured limb skeletal progenitors accom-
panied with changes in global and regional DNA methy-
lation. In a complementary fashion, knockdown of these
genes stimulated chondrogenesis and inhibited cell death
and senescence. We identiﬁed Sox9, Scleraxis, Bak1, and
p21 as potential transcriptional targets responsible for its
function in the developing digit model.
Materials and methods
We employed Rhode Island chicken embryos from day
4 to day 8.5 of incubation (id) equivalent to stages 23–34
HH, and C57BL6 mouse embryos ranging from 12 to
14.5 days post coitum (pc).
In situ hybridization and analysis of cell proliferation
In situ hybridization of PFA-ﬁxed limb specimens was
performed in whole mount or 100-μm vibratome sections.
The samples were treated with 10 μg/ml of proteinase K
for 20–30min at 20 °C. Hybridization with digoxigenin-
labeled antisense RNA probes was performed at 68 °C.
Alkaline phosphatase-conjugated antidigoxigenin anti-
body (dilution 1:2000) was used (Roche). Reactions were
developed with BM Purple AP Substrate precipitation
(Roche).
The probes for Uhrf1 and Uhrf2 were obtained by PCR
from RNA extracted from chick or mouse limb buds at
initial stages of digit formation. Speciﬁc primers for chick
Uhrf1 were: 5′-tccacatctattgcctcaacc-3′ and 5′-gaacacca-
gattcgctcacc-3′; for chick Uhrf2 5′-agagttcaggtgagcgaagc-
3′ and 5′-aggctcaacgtcatctctcc-3 and for mouse Uhrf1: 5′-
tgactctggctatggtgtgg-3′ and 5′-gcctgatgttgccgtatagc-3′;
and for mouse Uhrf2 5′-agagttcaggtgagcgaagc-3′ and 5′-
tcgttcgattccttctgagg-3′.
The distribution of proliferating cells in the autopod
was analyzed in parafﬁn-embedded tissue sections by
detection of bromodeoxyuridine (BrdU) incorporation
60min after injection into the amniotic sac of 100 μl of
BrdU solution (100 mg/ml).
Cell senescence, neutral red vital staining, TUNEL assay,
and immunoﬂuorescence
The β-galactosidase activity assay20 was performed at
pH 6 in vibratome sections of limb autopods ﬁxed in 4%
glutaraldehyde.
Neutral red staining, TUNEL assay, and electron
microscopy were performed as described previously2.
Immunolabeling was performed in limb tissue samples
ﬁxed in 4% PFA. We employed both squashed interdigital
tissue fragments or vibratome sections permeabilized with
Triton X-100 in PBS. The following antibodies were
employed: rabbit monoclonal anti-UHRF1 (DSG8E, Cell
Signaling), rabbit polyclonal anti-UHRF2 (TA337863,
OriGene); mouse monoclonal anti-UHRF2 (sc-398953,
Santa Cruz Biotechnology); mouse monoclonal anti-5-
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methylcytosine (5-mC; 33D3, Eurogentech); rabbit poly-
clonal anti-SOX9 (AB5535,Milipore); mouse monoclonal
anti-γH2AX (JBW301, Milipore-Upstate); and mouse
monoclonal anti-BdrU (BU-33, Sigma Aldrich). Coun-
terstaining to distinguish nucleus and cytoplasm was
performed using ﬂuorescent-phalloidin (Sigma Aldrich)
or DAPI (Vector Laboratories). Observation were made
with a LSM51O laser confocal microscope (Zeiss).
In vivo treatments
The transcriptional effects of FGF signaling in the
expression of Uhrf genes were studied by analyzing the
effects of the local administration of FGF2 (diluted at
0.5 mg/ml, Peprotech), and the FGF inhibitor SU5402
(diluted at 4 mg/ml, Calbiochem), using heparin acrylic
(Sigma) or ion exchange (AG1-X2, Bio-Rad) microbeads
as described21.
Mesodermal cultures
Dissociated undifferentiated mesoderm from chick leg
autopods at 4.5 i.d. (25 HH) were cultured as micromasses
containing a density of 2.0 × 107 cells/ml. The chondro-
genic outcome was studied under the microscope after
Alcian blue staining (0.5% Alcian blue, at pH 1.0).
Chondrogenesis was further quantiﬁed by the detection of
Alcian blue dye extracted in 6M guanidine–HCl (pH 5.8),
and the optical density was measured at 600 nm.
Cell nucleofection and targeted gene silencing
Functional studies were performed by gain-of-function
and loss-of-function approaches.
For gain-of-function experiments, skeletal progenitors
were electroporated with constructs of chicken Uhrf1
(cUhrf1; OGa47434) or Uhrf2 genes (cUhrf2; OGa21255)
cloned into the pcDNA3.1 vector (GenScript) employing
the Multiporator System (Eppendorf) and cultured under
high-density conditions as indicated above. For loss-of-
function experiments, skeletal progenitors were electro-
porated with a short hairpin RNAi against Uhrf1 (sh-Uhrf1)
or Uhrf2 (sh-Uhrf2) cloned into the pcU6–1-shRNA (a
generous gift from Dr. Tim J. Doran). Transfections with
the respective empty plasmids were employed as controls.
After 48 h of culture, the level of gene regulation was
conﬁrmed by q-PCT and/or Western blot analysis.
Evaluation of DNA methylation
Changes in global methylation after Uhrf functional
experiments were determined by the ELISA-based com-
mercial kit Imprint® Methylated DNA Quantiﬁcation
(MDQ1; Sigma-Aldrich, St. Louis, MO, USA). One hun-
dred and ﬁfty nanograms of genomic DNA from our
samples were incubated with capture and detection anti-
bodies and their absorbance was measured at 450 nm. The
amount of methylated DNA present in the samples is
proportional to the absorbance measured. Quantiﬁcation
of global DNA methylation was performed calculating
methylation levels relative to the methylated control DNA
(50 ng/µl) using the formula: [(A450 av sample–A450 av
blank)/(A450 av methylated control DNA–A450 av
blank)] × 100.
We next selected Bak1 as potential target of Uhrf genes
in the control of cell death. Changes in the methylation
status of its promoter were studied by methylation sen-
sitive restriction enzyme and quantitative polymerase
chain reaction (MSRE-qPCR). Primers were designed
using Primer3Plus online software. The selected PCR
primer pair ﬂanked the region of interest (based on the
presence of informative restriction sites) within the pro-
moter of Bak1: Fwd, AGCTGCAGCCTTCCCAGA; Rev,
CTCTAGAGGCGCCTTGCAC. Genomic DNA samples
were digested with a CpG-methylation-sensitive restric-
tion enzyme (TauI (3 U/µl); ER1651 ThermoFisher Sci-
entiﬁc) or with a non-CpG-methylation-sensitive enzyme
(SacI (10 U/µl); ER1132 ThermoFischer Scientiﬁc) for 2 h
according to the manufacturer's suggested temperature.
SYBRGreen-based qPCR was carried out in triplicates
with a total volume of 20 µl per tube containing 1 µl of
genomic DNA (TauI-digested, SacI-digested, or undi-
gested DNA), 0.4 µl of each primer, 10 µl of SYBR Select
Master Mix (Life Technologies), and 8.2 µl of H2O.
Reactions were carried out in a StepOne Real Time Sys-
tem and analyzed by StepOne software v2.3 (Life Tech-
nologies). The relative percentage of methylated DNA was
calculated according to the equation 2−ΔΔCt employing as
normalizers the Ct values of both SacI digested and
undigested samples22.
Western blot analysis
The total amount of UHRF proteins in control and
treated tissue samples was evaluated by Western blot
analysis. Total proteins were extracted by lysis from
interdigits or dissociated micromass cultures. After
determining the protein concentration, 30 µg of each
sample was loaded onto a 12.5% SDS polyacrylamide gel,
electrophoresed and transferred to PVDF membranes.
The membranes were incubated with primary antibodies
(see “Immunoﬂuorescence” section). Protein bands were
detected with an OdysseyTM Infrared-Imaging System (Li-
Cor Biosciences). Immunoblots were developed with anti-
mouse IRDye800DX or anti-rabbit IRDye680DX as sec-
ondary antibodies (Rockland Immunochemicals, USA).
Flow cytometry
Control, Uhrf1 or Uhrf2 gene-overexpressing, or Uhrf1
or Uhrf2 gene-silenced cultures were dissociated. One
million cells were used in each test. For propidium iodide
(PI) staining, the cells were washed with PBS and ﬁxed in
90% ethanol. The samples were incubated overnight at
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4 °C with 0.1% sodium citrate, 0.01% Triton X-100, and
0.1 mg/ml PI. The cell suspension was subjected to ﬂow
cytometry analysis in a Cytoﬂex (Beckman Coulter) and
analyzed with the Cytexpert software.
Real-time quantitative PCR (q-PCR) for gene expression
analysis
Total RNA was extracted using the NucleoSpin RNA kit
(Macherey-Nagel). First-strand cDNA was synthesized
using random hexamers and the High Capacity cDNA
Reverse Transcription Kit (Life Technologies). The cDNA
concentration was adjusted to 0.5 μg/μl. SYBRGreen (Life
Technologies)-based q-PCR was performed using the
Mx3005P system (Stratagene). Rpl13 was chosen as the
normalizer in interdigital samples and Gapdh in cultures.
Mean values for fold changes were calculated. Expression
level was evaluated relative to a calibrator according to the
2−(ΔΔCt) equation. Each value represents the mean ± SEM
of at least four independent samples obtained under the
same conditions. Data were analyzed using Student’s t-
test or ANOVA followed by Bonferroni test for post-hoc
comparisons. Statistical signiﬁcance was set at p < 0.05. q-
PCR-speciﬁc primers analyzed in this study would be
provided upon request.
Results
Interdigital and interphalangeal joint expression domains
of UHRF1 and UHRF2 in the embryonic limb
A preliminary search for the interdigital expression of
epigenetic regulators revealed high expression levels of
Uhrf1 and Uhrf2 genes compared with interdigital gene
markers23 (Supplementary Fig. 1). Therefore, we gener-
ated probes to explore their expression by in situ hybri-
dization. As shown in Fig. 1a–j, Uhrf genes show similar
expression pattern in the interdigital mesoderm, preced-
ing (id 5–6) and during the whole remodeling period (id
6.5–8; Fig. 1a–j). This period is characterized by pro-
liferation arrest24,25(Fig. 1m), and degeneration detectable
by β-galactosidase labeling (Fig. 1o), neutral red vital
staining (Fig. 1p), γH2AX immunolabeling (DNA damage
marker; Fig. 1q), and TEM (Fig. 1r). Analysis of the gene
expression in tissue sections (Fig. 1e, j) detected additional
domains in the developing interphalangeal joints that
mark a region where cells also undergo programmed cell
death and senescence (Fig. 1o). Quantiﬁcation of inter-
digital gene expression showed that Uhrf1, after a short
downregulation preceding id 6, maintained in subsequent
stages expression levels higher than other interdigital
tissue markers (Fig. 1k, see also Supplementary Fig. 1). In
contrast, the expression level of Uhrf2 remained relatively
constant throughout the course of tissue remodeling (Fig.
1l). Western blot analysis conﬁrmed the presence of high
levels of UHRF1 and UHRF2 proteins through the course
of interdigit remodeling (Fig. 1n).
A similar expression pattern for both genes was
observed in mouse embryos. As shown in Fig. 2, by day 12
pc, Uhrf genes are expressed in the undifferentiated
autopodial mesoderm and in subsequent stages, expres-
sion becomes restricted to the interdigital mesoderm. By
day 14 pc, interdigit regression is almost accomplished
and Uhrf gene expression become restricted to the zones
of joint formation (Fig. 2d, h)
Cellular distribution of UHRF in the interdigital mesoderm
The protein distribution was analyzed by immuno-
ﬂuorescence in mouse and chick interdigits (Figs. 3 and
4). Both proteins showed a diffuse pattern throughout the
nucleus with distinctive foci of labeling intensiﬁcation
(Figs. 3a and 4a). Moderate cytoplasmic immunolabeling
was also observed (Fig. 4a). The association of UHRF
proteins with epigenetic markers and degenerative events
was next explored (Figs. 3b–d and 4b–d). We ﬁrst ana-
lyzed the relation between UHRF proteins and methylated
DNA monitored with 5-mC immunolabeling. In chick
cells, 5-mC immunolabeling appeared as dots of variable
size (Fig. 3b´ and c´, and 4c´). In mouse cells, 5-mC
labeling appeared as characteristic rings (Fig. 4b´). In both
species UHRF1 and UHRF2 spots were often associated
with 5-mC-positive marks. Of note, UHRF proteins often
occupied the core of the 5-mC rings in mouse cells (inset
of Fig. 3b´´, and Fig. 4b´´). Colocalization of UHRF pro-
teins with 5-mC foci were appreciated for UHRF1 (Fig.
3b). This overlapping expression is consistent with the
demonstrated role of UHRF1 in recruiting DNA methyl
transferase 1 and histone deacetylase 1 to chromatin
regions containing CpG dinucleotides. Of relevance,
immunolabeling for both UHRF1 and 2 appeared inten-
siﬁed at the initial stages of the dying process (Figs. 3c and
4c). These initial stages of cell degeneration are identiﬁed
by a progressive loss and peripheral displacement of 5-mC
labeling. In contrast, at stages of overt apoptosis UHRF
positivity was lost (Figs. 3d and 4d).
Regulation of Uhrf gene expression by FGF signaling
The growth and differentiation of the limb skeletal
progenitors is controlled by FGFs. FGFs maintain pro-
liferation and delay cell death and chondrogenic differ-
entiation21,26–28. The degeneration of the interdigital
tissue and the completion of digit formation are asso-
ciated with the extinction of FGF signaling. Therefore, we
investigate the inﬂuence of FGFs on the expression of
UHRF genes. As shown in Fig. 5a–f, the expression levels
of FGF8 and FGF10, which are the most characteristic
FGF genes expressed in the autopod at the studied stages,
become downregulated at id 6 (Fig. 5a–f). As described
above (Fig. 1k), id 6 is the period that marks the decreased
expression of Uhrf1. In subsequent stages, when down-
regulation of FGFs is intensiﬁed, both Uhrf1 and Uhrf2
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Fig. 1 Uhrf genes are expressed in the remodeling interdigits. Expression of Uhrf1 (a–e) and Uhrf2 (f–j) in the interdigital tissue and joint forming
regions of chick leg buds.Whole mount in situ hybridizations at id 5 (a), 4.5 (f), 5.5 (b and g), 6.5 (c, h), and 7.5 (d, i). Arrowheads in g and h show a
characteristic absence of Uhrf2 transcripts in the subridge mesoderm. e and j are in situ hybridizations in vibratome tissue sections at id 7.5 to show
the joint domains (arrows) of Uhrf1 (e), and Uhrf2 (j). k and l are charts showing the expression levels of Uhrf1 (k) and Uhrf2 (l) in the course of
interdigit tissue remodeling, considering a value of 1 for id 5.5. Note the decreased expression of Uhrf1 between id 5.5 and 6. m BrdU incorporation
to mark mitosis in the autopod at id 6. Note the almost absence of cells labeled in the interdigital tissue (ID) compared with the digit regions
(d). n Western blotting showing the UHRF1 and UHRF2 proteins in the interdigital tissue at id 5.5 and 7.5 the stage preceding and the peak
of degeneration. o–r illustrations of the most characteristic features of the third interdigit in autopods at the peak of degeneration (id 7.5).
o Senescence-speciﬁc beta-galactosidase activity. Note positivity in the interdigit (ID) and in the developing joints (arrows); p interdigit after neutral
red vital staining; q immunolabeling with anti-γ-H2AX showing interdigital cells undergoing DNA damage. Digit rays are labeled red with anti-Sox9;
r transmission electron microscopic image to show the abundance of dark apoptotic cells in the interdigital mesoderm. ***p < 0.001. Bars= 200 µm
(a–j, m, o–q). Bar= 15 µm (r)
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remain expressed at high levels. Interdigital application of
a FGF-bead moderately upregulated the expression of
Uhrf1 (Fig. 5g, h and j), but not Uhrf2 (Fig. 5k–l and n). In
contrast, the local application of the FGF inhibitor
SU5402 downregulated both Uhrf genes (Fig. 5i, j, and m,
n). Together, these ﬁndings suggest that FGF signaling
promotes only the expression of Uhrf1 but sustains the
expression of both Uhrf genes.
Expression and functional analysis of Uhrf genes during
chondrogenic differentiation
The absence of Uhrf transcripts in the differentiating
digit rays revealed these factors as potential inhibitors of
chondrogenic differentiation. To test this hypothesis we
monitored their expression in micromass cultures of limb
skeletal progenitors (Fig. 6). This in vitro assay mimics the
process of digit cartilage differentiation in vivo. The ske-
letal progenitors grow initially in an undifferentiated state,
but by 48 h of culture, they aggregate to form chondro-
genic nodules (Fig. 6a). The nodules are separated from
each other by cells that retain morphological and tran-
scriptional characteristics of ﬁbrous connective tissue29.
In subsequent days of culture, the chondrogenic nodules
increased in number and size (Fig. 6a–c), forming by the
end of the second week an almost continuous sheet of
cartilage30. Uhrf1 expression showed the highest levels on
day 1 of culture, but the expression declined to half by day
2, progressing to more moderate levels during subsequent
days of culture (Fig. 6d). At difference of Uhrf1, Uhrf2
maintained uniform expression levels during the ﬁrst
4 days of culture (Fig. 6e). These results are compatible
with an antichondrogenic role, at least for Uhrf1.
To further explore their potential role in chondrogen-
esis, a functional analysis of Uhrf genes was performed by
gain-of-function and loss-of-function experiments in the
micromass assay (Fig. 6f–i). Chondrogenesis was sig-
niﬁcantly downregulated in 5-day cultures of progenitors
transfected with either Uhrf1 (Fig. 6f) or Uhrf2 (Fig. 6h)
genes. In a complementary fashion, chondrogenesis was
signiﬁcantly upregulated after the knockdown of either
Uhrf1 (Fig. 6g) or Uhrf2 (Fig. 6i), via transfection of the
corresponding sh-RNAi.
Uhrf genes modulate cell death and cell cycle progression
of skeletal progenitors
From our previous experiments, we concluded that Uhrf
genes inhibit mesenchymal precursor differentiation. As
mentioned above, skeletal progenitors that do not differ-
entiate during limb development, undergo senescence and
cell death. Therefore, we next explored whether Uhrf
genes inﬂuenced the degenerative fate of the excess pro-
genitors. For this purpose, changes in cell proliferation
and death were analyzed in the micromass culture assay.
After 2 days of culture, cell death was signiﬁcantly regu-
lated in gain-of-function and loss-of-function experi-
ments (Fig. 7a). Over-expression of Uhrf1 increased the
number of dead cells more than three times, and its
silencing decreased cell death by 25%. In turn, the over-
expression of Uhrf2 increased cell death by two-fold, and
its knockdown decreased cell death by 35%. Changes in
the intensity of cell death were accompanied by cell cycle
arrest in the S-phase (Fig. 7b, c). Hence, the rate of cells in
the S phase increased by 150% after Uhrf1 overexpression
and was reduced by 20% in loss-of-function experiments
(Fig. 7b). The effect of Uhrf2 on cell cycle progression was
less consistent. Uhrf2 overexpression increased the
number of cells in S phase by 20% and silencing reduced S
phase cells at a similar rate (Fig. 7c). Together, these
ﬁndings are consistent with the arrest of cell cycle at S
phase, as occurs in response to DNA damage.
Fig. 2 In situ hybridizations showing the expression of Uhrf1 (a–d) and Uhrf2 (e–h) in the mouse autopod during interdigit remodeling. a–
d show the expression of Uhrf1 at pc days 12 (a), 13 (b), 13.5 (c), and 14 (d). Note the presence of joint domains by pc 14 (arrows in d). e–h show the
expression of Uhrf2 at pc days 12.5 (e),13 (f), 13.5 (g), and 14 (h). Note the fading of the interdigital domains in the distal subectodermal region
(arrows in e and f). Bars= 500 µm
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Transcriptional inﬂuence of Uhrf genes
UHRF factors act through the modulation of gene
expression at the transcriptional level. Therefore, we next
explored the inﬂuence of Uhrf genes in the transcription
of a panel of genes associated with differentiation, pro-
liferation, and apoptosis of limb mesenchymal progenitors
(Table 1).
The dual differentiation of limb skeletal progenitors is
regulated by a balance between Sox9, and Scleraxis, which
are master chondrogenic and ﬁbrogenic genes31,32,
respectively. Both genes regulate the dichotomic differ-
entiation of progenitors into cartilage or ﬁbrous tissue.
Increased chondrogenesis in knockdown experiments was
preceded by downregulation of Scleraxis, while the
Fig. 3 UHRF1 immunolabeling (red) of chick interdigital cells at 7 id. a–a´´ UHRF1 (red) in combination with phalloidin (green) show the nuclear
localization of UHRF1. (a) UHRF1 labeling, (a´) phallodin labeling showing cytoplasmic actin; (a´´) merged images. (b–b´´) UHRF1 (red) in combination
5-mC immunolabeling (green) to show the overlapping distribution of UHRF1 in zones of DNA methylation (arrow). (b) UHRF1 labeling; (b´) 5-mC
immunolabeling; (b´´) merged images; inset in this image shows the association between UHRF1 and 5-mC rings in mouse interdigital cells. (c–c´´)
Double immunolabeling for UHRF1 (red) and 5-mC (green) to show the increased UHRF1 labeling in cells with reduced DNA methylation (arrows). (c)
UHRF1 labeling; (c´) 5-mC immunolabeling; (c´´) merged image. (d–d´´) Immunolabeling of UHRF1 (red) in combination with TUNEL (green) to show
the loss of UHRF1 in TUNEL-positive apoptotic cells (arrows). (d) UHRF1 labeling; (d´) TUNEL labeling; (d´´) merged image. Bar= 10 µm
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upregulation of Sox9 was not detectable until the overt
differentiation of the micromass cultures (day 4 of cul-
ture). In contrast, the downregulation of Sox9 in experi-
ments of gain-of-function experiments was more
precocious than the changes in the expression of
Scleraxis.
The expression analysis of members of the Bcl2 cell
death gene family showed a signiﬁcant regulation of Bak1
in association with changes in the intensity of cell death.
The overexpression of Uhrf1 increased Bak1 expression
by 250%, while gene silencing decreased Bak1 expression
by half. Uhrf2 functional experiments caused a similar but
more moderate regulation of Bak1. Other members of the
Bcl2 gene family, were either not regulated or moderately
regulated (Table 1).
To explore the inﬂuence of Uhrf genes in cell senes-
cence we selected p21 as the most conspicuous marker of
embryonic developmental senescence. As shown in Table
1, p21 was upregulated six-fold after Uhrf1 overexpression
and two-fold after Uhrf2 overexpression. In turn, p21 was
signiﬁcantly downregulated after the knockdown of either
Uhrf1 (0.5×) or Uhrf2 (0.3×).
Fig. 4 UHRF2 immunolabeling of interdigital cells. UHRF2 immunolabeling (red) of chick (a, c, d) and mouse (b) interdigital cells.(a–a´´) UHRF2
(red) in combination with phalloidin (green) showing the occurrence of both nuclear and cytoplasmic (arrow) localization of UHRF2. (a) UHRF2
labeling, (a´) phallodin labeling showing cytoplasmic actin; (a´´) merged images. (b–b´´) UHRF2(red) in combination 5-mC immunolabeling (green) to
show the presence of UHRF2 positivity in the core of 5-mC rings (arrows). (b) UHRF2 labeling; (b´) 5-mC immunolabeling; (b´´) merged images. (c–c´´)
Double immunolabeling for UHRF1 (red) and 5-mC (green), to show the increased immunolabeling in cells with reduced DNA methylation (arrows).
(c) UHRF2 labeling; (c´) 5-mC immunolabeling; (c´´) merged image. (d–d´´) Immunolabeling of UHRF1 (red) in combination with TUNEL (green) to
show the loss of UHRF2 in apoptotic cells TUNEL-positive (arrows). (d) UHRF1 labeling; (d´) TUNEL labeling; (d´´) merged image. Bar= 10 µm
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Fig. 5 Regulation of Uhrf genes by FGF signaling. a, b Expression of Fgf8 in the limb marginal ectoderm (AER) at id 5.5 (a) and 7 (b). c q-PCR
analysis of the expression decay of Fgf8 gene expression from 5.5 to 7.5 id in samples of the interdigital tissue. d, e expression of Fgf10 in the
autopods at id 5.5 (e) and 7,5 (f). f q-PCR analysis of the expression decay of Fgf10 gene expression from 5.5 to 7.5 id in samples of the interdigital
tissue. g–j Regulation of Uhrf1 by FGF signaling. g–i expression of Uhrf1 in control interdigit at id 7.5 (g); 12 h after implantation of a FGF-bead (arrow,
h); and 12 h after implantation of a SU5402 bead (arrow, h). I q-PCR analysis of the regulation of Uhrf1 in control interdigits and 12 h after
implantation of a FGF2 bead and SU5402 beads. k–n Regulation of Uhrf2 by FGF signaling. k–m expression of Uhrf2 in control interdigit at id 7.5 (k);
12 h after implantation of a FGF-bead (arrow, l); and 12 h after implantation of a SU5402 bead (arrow, m). n q-PCR analysis of the regulation of Uhrf2
in control interdigits and 12 h after implantation of a FGF2 bead and SU5402 beads. ***p < 0.001; **p < 0.01; *p < 0.05 versus control. ###p < 0.001; ##p
< 0.01 between the two treatments. Bars= 200 µm
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Regulation of DNA methylation by Uhrf genes
Considering the functional implication of UHRFs in
genomic DNA methylation, we ﬁrst analyzed changes in
global methylation in micromass cultures subjected to Uhrf
gene overexpression or silencing. Global methylation was
signiﬁcantly increased in 2-day cultures transfected with
Uhrf1 or Uhrf2 genes (Fig. 8a), but was not modiﬁed at
statistical signiﬁcant levels when progenitors were subjected
to Uhrf´s gene silencing. However, we detected a mild
decrease in global methylation after Uhrf1 gene silencing.
To address the functional signiﬁcance of methylation in
the regulation of cell death by Uhrf genes, we select Bak1
Fig. 6 Uhrf genes and chondrogenesis of limb skeletal progenitors. a–c Limb skeletal progenitors cultured at high density (micromass) for 2 (a),
3, (b) and 4 (c) days stained with Alcian blue for chondrogenesis. Note the increase in the size of the cartilage nodules stained in blue. Bar= 200 µm.
d q-PCR quantiﬁcation of Uhrf1 gene expression in micromass cultures of 1, 2, and 4 days. Note the downregulation of Uhrf1 during the course of
chondrogenic differentiation. e q-PCR quantiﬁcation of Uhrf2 gene expression in micromass cultures of 1, 2, and 4. In contrast to Uhrf1, Uhrf2 is not
downregulated in the differentiating cultures. f–i evaluation of cartilage differentiation by guanidine–HCl extraction of Alcian blue dye (illustrated in
the lower row of pictures) in functional experiments of Uhrf genes gain-of-function (f and h) and loss-of-function (g and i). Note the inhibition of
differentiation after the overexpression of Uhrf1 (f) and Uhrf2 (h), and the increased chondrogenesis after knockdown of Uhrf1 (g) and Uhrf2 (i). ***p <
0.001; **p < 0.01; *p < 0.05 treated versus control
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to explore methylation changes in CpG islands of its
promoter by MSRE-qPCR (Fig. 8b). Gain-of-function
experiments of both Uhrf1 or Uhrf2 were followed by
decreased methylation. The decrease was particularly
intense after Uhrf1 overexpression, and more moderated
for Uhrf2. As observed for global methylation, gene
silencing did not change at signiﬁcant levels methylation
of Bak1 promoter.
Functional redundancy of Uhrf genes
We ﬁrst analyzed the inﬂuence of Uhrf genes on the
expression of each other. As shown in Table 1, neither
overexpression nor gene silencing of the Uhrf1 gene
regulated the expression of Uhrf2 at signiﬁcant levels.
However, overexpression and silencing of Uhrf2 were
followed by a moderate regulation of Uhrf1.
We next analyzed by ﬂow cytometry changes in cell
death in combined transfections of overexpression plas-
mids and sh-RNA inhibitory constructs (Supplementary
Fig. 2A, B). Transfection of Uhrf2 in combination with
shRNAi-Uhrf1 neutralized the cell death promoting effect
of Uhrf2 (Supplementary Fig. 2A). In these experiments,
the intensity of cell death became similar to that observed
after transfections with shRNAi-Uhrf1 only. In a similar
fashion, the inhibitory inﬂuence on cell death of sh-RNAi-
Uhrf2 was also abolished when it was co-transfected with
Uhrf1 (Supplementary Fig. 2B). Finally, the increased cell
death induced separately by Uhrf1 or Uhrf2 lacked sta-
tistically signiﬁcant differences with the level of cell death
induced by double transfections with both Uhrf genes
(Supplementary Fig. 2C). Together, these ﬁndings suggest
common and complementary roles for both genes in the
embryonic limb mesoderm.
Discussion
Current knowledge of the role of UHRF proteins in
developing vertebrates is scarce because mouse KO for
Uhrf1 die early in gestation33, and mice deﬁcient in Uhrf2
lack skeletal phenotype18. However, the implication of
Uhrf1 in the formation and growth of various organs has
been observed in mutant zebraﬁsh embryos16, and the
inﬂuence of Uhrf1 in cartilage maturation, has been
Fig. 7 Regulation of cell death and cell cycle by UHRFs. a Chart showing differences in the intensity of cell death evaluated by ﬂow cytometry
between control progenitors and progenitors overexpressing (oe) or subjected to silencing (shRNAi) of Uhrf1 (white columns) and Uhrf2 (gray
columns).The level of cell death in control cultures was considered 100% and is represented by the dotted line. b Graphic illustrations comparing the
proportion of cells at different cell cycle stages in cultures overexpressing Uhrf1 (white columns) and after gene silencing (gray columns) versus
control cultures (represented by the dotted line). c Graphic illustrations comparing the proportion of cells at different cell cycle stages in cultures
overexpressing Uhrf2 (white columns) and after gene silencing (gray columns) versus control cultures (represented by the dotted line). ***p < 0.001;
**p < 0.01; *p < 0.05 treated versus control
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demonstrated via a conditional knockout (Uhrf1-cKO)
targeted to the limb mesoderm17. The skeletal phenotype
of Uhrf1-cKO mice provided evidence for a role for
UHRF1 in the elongation of appendicular bones during
the postnatal period by regulating the growth and differ-
entiation of the growth plates. Our study extends the
function of these genes to the stages of digit
skeletogenesis. Our study showed that Uhrf genes inhibit
the chondrogenesis of skeletal progenitors. This function
contrasts with the requirement of UHRF1 for the differ-
entiation of postnatal chondrocytes grown in micromass
culture17. These different effects emphasize the depen-
dence of Uhrf genes on their functions of factors whose
presence in the cells is related to the stage of differ-
entiation. In the embryo, the expression domains of Uhrf1
and Uhrf2 speciﬁcally mark undifferentiated progenitors.
Furthermore, in the case of Uhrf1, the level of expression
in vitro becomes progressively reduced in parallel with the
differentiation of the progenitors into chondrocytes.
These observations support a role for Uhrf genes, espe-
cially Uhrf1, in the maintenance of progenitors in an
undifferentiated state.
We identiﬁed Sox9 and Scleraxis, as potential mediators
for the antichondrogenic inﬂuence of UHRFs on the
skeletal progenitors. Sox9 belongs to the high-mobility
group of chromatin regulators and plays a central role in
the differentiation of skeletal progenitors34–36. Scleraxis, is
a basic helix-loop-helix transcription factor structurally
associated with Sox9 and is involved in the formation of
ﬁbrous connective tissues31,35. Sox9 promotes the onset of
chondrogenic differentiation in the developing limb and
its silencing leads to cell death of skeletal progenitors34,37.
The function of SOX9 is modulated by epigenetic
mechanisms via histone acetylation on chromatin35.
Remarkably, in our study, the chondrogenic inhibition
and increased cell death in Uhrf gene gain-of-function
experiments involved a precocious downregulation of
Sox9. In contrast, increased chondrogenesis in loss-of-
function experiments were preceded by downregulation
of Scleraxis. This ﬁnding suggests a double and com-
plementary function of Uhrf genes via the activation or
Table 1 Transcriptional analysis of limb progenitors
subjected to gain-of-function and loss-of-function of either
Uhrf1 or Uhrf2 genes
cUhrf1 shUhrf1 cUhrf2 shUhrf2
Differentiation markers
Scx 1.02 ± 0.11 0.59 ± 0.06*** 1.17 ± 0.20 0.50 ± 0.09***
Sox9 0.59 ± 0.07*** 0.93 ± 0.09 0.59 ± 0.08*** 0.80 ± 0.15
Senescence marker
p21 6.18 ± 1.98* 0.56 ± 0.07*** 2.36 ± 0.35** 0.38 ± 0.08***
Cell death markers
Bcl2 1.24 ± 0.10 1.12 ± 0.06 0.89 ± 0.07 1.01 ± 0.14
Bak1 2.44 ± 0.51** 0.59 ± 0.03*** 1.80 ± 0.34* 0.80 ± 0.10
Bid 1.45 ± 0.21 0.85 ± 0.06 1.24 ± 0.15 0.92 ± 0.15
Bim 0.99 ± 0.04 1.24 ± 0.12 0.91 ± 0.19 0.98 ± 0.12
Bmf 1.72 ± 0.31* 0.94 ± 0.08 1.02 ± 0.13 0.89 ± 0.14
Uhrf1 10.33 ± 2.88** 0.44 ± 0.03*** 1.98 ± 0.35* 0.69 ± 0.07***
Uhrf2 1.26 ± 0.12 0.95 ± 0.05 10.31 ± 2.53** 0.50 ± 0.04***
The panel of genes analyzed included markers for skeletogenic differentiation,
senescence, and apoptosis
***p < 0.001; **p < 0.01; *p < 0.05 treated versus control
Statistic signiﬁcant values are highlighted in bold
Fig. 8 Changes in DNA methylation by UHRFs. a Chart showing differences in global methylation evaluated by ELISA between control progenitors
and progenitors overexpressing (oe) or subjected to silencing (shRNAi) of Uhrf1 (white columns) and Uhrf2 (gray columns).The level of global
methylation in control cultures was considered 100% and is represented by the dotted line. b Methylation level of CpG islands in the Bak1 promoter
evaluated by MSRE-qPCR between control progenitors and progenitors overexpressing (oe) or subjected to silencing (shRNAi) of Uhrf1 (white
columns) and Uhrf2 (gray columns). The level of CpG methylation in control cultures was considered 100% and is represented by the dotted line.
***p < 0.001; **p < 0.01; *p < 0.05 treated versus control
Sanchez-Fernandez et al. Cell Death and Disease          (2019) 10:347 Page 12 of 14
Ofﬁcial journal of the Cell Death Differentiation Association
repression of the promoters of master genes that establish
the fate of the skeletal progenitors.
UHRF proteins play pivotal functions in carcinogenesis
modulating DNA methylation and the histone functional
code of tumor cells38–40. Consistent with these facts, here
we show that both Uhrf genes promote global methylation
in skeletal progenitors. Changes induced in cancer cells by
dysregulation of Uhrf genes include cell proliferation, cell
senescence, apoptosis, increased metastatic potential, and
increased sensitivity to DNA-damaging agents14,15,40–44.
In most cases the function of UHRF proteins takes place
in coordination with other chromatin-modifying pro-
teins44. This feature explains that the function of UHRF
proteins varies in a cell cycle-dependent and cell lineage-
dependent manner.
The degenerative events accounting for interdigit remo-
deling occur in a sequential fashion. In the 12–24 h pre-
ceding the onset of massive apoptosis, the interdigital cells
undergo proliferation arrest24, and intense DNA damage5.
These changes are next followed by senescence4 and mas-
sive apoptosis to accomplish interdigit removal. Between id
5.5 and id 6, we observed a partial decrease in the inter-
digital expression of Uhrf1 that correlated with the down-
regulation of FGF genes at the end of limb morphogenesis.
In subsequent stages of degeneration (from id 6.5 to id 8)
both UHRF1 and UHRF2 maintained elevated protein and
transcriptional expression levels, suggesting an active par-
ticipation of both UHRF proteins in tissue regression.
Our functional approaches established the implication
of both Uhrf genes in the regulation of the cell death of
skeletal progenitors, and in the expression of p21, a gene
that plays a pivotal role in embryonic developmental
senescence4. Additionally, the overexpression of Uhrf
genes arrested the cell cycle in S phase, a characteristic
feature of senescent cells associated with DNA damage.
Cell death appeared signiﬁcantly upregulated in progeni-
tors overexpressing either Uhrf1 or Uhrf2, and sig-
niﬁcantly reduced in loss-of-function experiments of
either gene. UHRFs have been implicated in the regula-
tion of apoptosis in tumoral systems by distinct
mechanisms, including the transcriptional regulation of
tumor suppressor genes38, selective regulation of pro-
apoptotic genes14,45, the induction of global hypomethy-
lation leading to changes in tumor radiosensitivity39, or by
reducing the capacity to repair DNA damage46. Remark-
ably, in our experimental system the intensiﬁcation and
attenuation of cell death correlated with changes in the
expression of Bak1, a characteristic proapoptotic member
of the Bcl2 gene family with a demonstrated role in the
regression of the interdigits47. Furthermore, up-regulation
of Bak1 was associated with hypomethylation of the CpG
islands of its promoter.
In normal cells, UHRF1 participates in the regulation of
the cell cycle, and in cooperation with the DNA methyl
transferase 1 (DNMT1), UHRF1 maintains the DNA
methylation status of dividing cells. It has been proposed
that Uhrf1 plays a primary role in cell senescence reg-
ulating the expression DNTM148. In our system, DNMT1
was not regulated by Uhrf1 or Uhrf2 (unpublished
observation), but, in turn, we detected an intense reg-
ulation of the cell senescence master gene p21 indicative
of the direct implication of these genes in cell senescence.
A similar regulation of p21 by Uhrf1 has been reported in
a number of systems44,49. However, in some tumoral cell
lineages, UHRF1 and UHRF2 exerted negative transcrip-
tional inﬂuence on the expression of p2150. This dis-
crepancy is explained by the importance of speciﬁc
cofactors that, together with UHRFs, form heteromeric
binding complexes in the promotors of target genes,
modulating their functions in a cell-cycle and cell-lineage-
dependent manner44.
In conclusion, our study uncovers a new level of reg-
ulation of interdigital apoptosis and cell senescence
upstream of the components of the intrinsic pathway
responsible for executing cell death in embryonic systems.
Furthermore, our ﬁndings indicate that the balance
between cell differentiation and cell stemness may be a
central step in the initiation of the so-called “programmed
cell death” associated with embryonic morphogenesis.
The epigenetic functional proﬁle of Uhrf genes in most
studied systems, together with the changes in DNA
methylation observed in our functional experiments,
suggests that the structural organization of the chromatin
may be a critical factor in the regulation of embryonic cell
death and cell senescence.
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